MGISEQ-2000

MGISEQ-2000 Timeline & PE150 Sequencing Overview

MGISEQ-2000 Timeline

  • 27 October 2017: ICG-12 debuts
  • 14 February 2018: Delivered to BGI Genomics, Gene+, WeGene, RIKEN Japan and others
  • Summer 2018: PE150 support introduced for MGISEQ-2000

 

About PE150 Sequencing

The PE150 reagent for MGISEQ-2000 provides high-throughput, accurate sequencing with consistent performance:

  • Average run time: 3 days
  • Effective reads per flow cell: up to 1,500M
  • Lanes per flow cell: 4
  • Effective reads per lane: ≥350M
  • Maximal sequencing cycles: 320

 

Data Performance

PE150 has been validated across multiple experiments, showing stable performance with E. coli samples:

  • Total reads: ≥350M per lane
  • Q30 quality score: consistently above 85%

 

Reproducibility

TestTotal Reads CVQ30 CV
Same batch of flowcells & reagents, 6 lanes3.24%1.13%
3 reagent batches, 25 lanes3.34%0.93%
3 instruments, 20 lanes2.76%0.93%
3 batches of flowcells, 6 lanes4.96%1.79%

Applications

PE150 demonstrates reliable performance across a wide variety of libraries:

  • Whole genome sequencing (WGS) – including PCR-free
  • Transcriptome analysis
  • Region capture & amplicon sequencing
  • Tumour panel sequencing

 

WGS Performance

  • Sample: NA12878
  • Base quality: Q20 97.2%, Q30 91.3%
  • SNP detection sensitivity: 99.48%
  • Indel detection sensitivity: 95.03%

 

Transcriptome Performance

  • Sample: Universal Human Reference RNA (UHRR)
  • MGISEQ-2000 showed ~2% higher genome mapping ratio and ~6% higher gene mapping ratio compared to N sequencing platform using B library prep kit
  • Gene and transcript numbers comparable across platforms
  • Coverage uniformity along gene bodies (5′–3′) comparable or better than other platforms

Summary

PE150 for MGISEQ-2000 ensures high-quality, reproducible sequencing for a wide range of applications. With stable performance, high sensitivity, and excellent coverage, PE150 is now available for order.

Total reads CV=3.24%, data quality Q30 CV=1.13%

Total reads CV=3.24%, data quality Q30 CV=1.13%

Reproducibility between 3 reagent batches (analyzing 25 lanes)

Total reads CV=3.34%, data quality Q30 CV=0.93%

Total reads CV=3.34%, data quality Q30 CV=0.93%

Reproducibility between 3 instruments (analyzing 20 lanes)

Total reads CV=2.76%, data quality Q30 CV=0.93%

Total reads CV=2.76%, data quality Q30 CV=0.93%

Reproducibility between 3 batch of flowcells (analyzing 6 lanes)

Total reads CV=4.96%, data quality Q30 CV=1.79%

Total reads CV=4.96%, data quality Q30 CV=1.79%

A wide range of applications

Stable and excellent performance with a variety of libraries tested: whole genome (including PCR-free), transcriptome, region capture, amplicon, tumor panel and more

  • WGS
  • Sample source: NA12878
  • Distribution of MGISEQ-2000 reads base and quality
Q20 97.2% Q30 91.3%
Q20 97.2% Q30 91.3%

Summary of WGS performancebetween sequencing platforms

Indel and SNP detection between sequencing platforms
Indel and SNP detection between sequencing platforms
·SNP detection sensitivity is up to 99.48% ·Indel detection sensitivity reaches 95.03%
·SNP detection sensitivity is up to 99.48% ·Indel detection sensitivity reaches 95.03%

Transcriptome

Sample source: UHRR

The Genome mapping ratio on the MGISEQ-2000 platform is about 2% higher than the N sequencing platform, and the Gene mapping ratio is about 6% higher than the B library prep kiton the N sequencing platform.

The MGISEQ-2000 platform showed similar results as of the N sequencing platform on Gene number and Transcript number.

Random comparison of reads between sequencing platforms

Relative Position in Genes (5' -> 3') (200 windows)

The randomness of the MGISEQ-2000 platform and the N sequencing platform of the B library prep kitis comparable, and the coverage at the 3′ end is better than that of the A library prep kiton the N sequencing platform.

● Of course, the advantages of PE150 reagent for MGISEQ-2000RS high-throughput genetic sequencer are far more than the above.

● Now PE150 is here waiting for you